YLN-13174-58655
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 975 / OR
- Registered
- 2021-07-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-22
Dose 1 — Pfizer-BioNTech
-
2021-07-13
Registered in v-safe
-
2021-07-13
Dose 2 — Pfizer-BioNTech
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-17
- 2021-07-19
- 2021-07-27
- 2021-08-04
- 2021-08-10
- 2021-08-19
- 2021-08-24
- 2021-10-12
- 2022-01-11
-
2022-01-14
Dose 3 — Pfizer-BioNTech
-
2022-01-20
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Congestion and sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-01-30
- 2022-02-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-22 | Pfizer-BioNTech | No |
| 2 | 2021-07-13 | Pfizer-BioNTech | No |
| 3 | 2022-01-14 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Congestion and sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release